257.14
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $257.14, with a volume of 1.21M.
It is down -0.94% in the last 24 hours and down -2.67% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$259.57
Open:
$258.91
24h Volume:
1.21M
Relative Volume:
1.87
Market Cap:
$21.13B
Revenue:
$13.95B
Net Income/Loss:
$877.70M
P/E Ratio:
24.59
EPS:
10.4589
Net Cash Flow:
$1.21B
1W Performance:
-5.68%
1M Performance:
-2.67%
6M Performance:
+3.63%
1Y Performance:
+6.95%
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc
|
257.14 | 21.33B | 13.95B | 877.70M | 1.21B | 10.46 |
|
TMO
Thermo Fisher Scientific Inc
|
466.26 | 174.74B | 45.20B | 6.88B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
178.80 | 126.68B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
IDXX
Idexx Laboratories Inc
|
553.66 | 45.14B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.30 | 32.46B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
292.13 | 29.52B | 3.17B | 642.63M | 516.49M | 10.77 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Labcorp slips after Q4 revenue miss - MSN
Labcorp earnings in focus as margin test looms for diagnostics giant - Investing.com Nigeria
What To Expect From Labcorp’s (LH) Q1 Earnings - Yahoo Finance
Labcorp Stock (US50540R4092): AI-Powered Platform Launch Accelerates Alzheimer's Research - AD HOC NEWS
Wall Street's Insights Into Key Metrics Ahead of Labcorp (LH) Q1 Earnings - Yahoo! Finance Canada
Labcorp Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Labcorp's Q4 earnings preview: What's in store for the stock? - MSN
Labcorp falls as 2025 revenue guidance midpoint lowered - MSN
Vanguard (LH) holds 6.20M shares, 7.52% stake disclosed in Schedule 13G - Stock Titan
Teacher Retirement System of Texas Sells 4,759 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Barclays Maintains Labcorp Holdings (LH) Equal-Weight Recommendation - MSN
Universal Beteiligungs und Servicegesellschaft mbH Has $24.01 Million Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
B. Metzler seel. Sohn & Co. AG Acquires 15,471 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Labcorp Holdings (LH) Stock Movers | Labcorp Holdings Inc notches 0.3% EPS beat, solid revenueLiquidity Risk - Xã Thanh Hà
Labcorp (LH) to Release Earnings on Thursday - MarketBeat
LH Labcorp Holdings reports modest Q4 2025 EPS beat and 7.2% YoY revenue rise, shares edge lower.Trending Momentum Stocks - UBND thành phố Hải Phòng
LH (Labcorp Holdings Inc.) delivers 7.2% YoY Q4 2025 revenue growth and small EPS beat, shares edge down 0.8%. - Xã Thanh Hà
Labcorp Holdings Inc. $LH Shares Acquired by M&T Bank Corp - MarketBeat
Labcorp launches diagnostic test for ovarian cancer treatment By Investing.com - Investing.com Canada
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA® (2026-04-22) - Seeking Alpha
Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA® - Sahm
A Look At Labcorp (LH) Valuation As New Tests And AI Alzheimer’s Platform Gain Traction - Sahm
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
All You Need to Know About Labcorp (LH) Rating Upgrade to Buy - Yahoo Finance
Labcorp Gears Up to Report Q1 Earnings: What's in Store? - Yahoo Finance
Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating a 14.55% Potential Upside for Investors - DirectorsTalk Interviews
Birch Hill Investment Advisors LLC Sells 37,071 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. $LH Stake Boosted by KBC Group NV - MarketBeat
Labcorp Holdings Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Illumina (ILMN), Labcorp (LH) expand precision oncology NGS collaboration - MSN
Is It Time To Reassess Labcorp (LH) After Its Recent Share Price Strength? - Sahm
Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes - Sahm
Sumitomo Mitsui Trust Group Inc. Sells 28,674 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp’s Rapid Fentanyl Test Clearance And What It Means For Valuation - Yahoo Finance
How Investors Are Reacting To Labcorp (LH) AI-Powered Real-World Data Push In Complex Disease Research - Yahoo Finance
Labcorp launches FDA-cleared rapid fentanyl urine test By Investing.com - Investing.com Canada
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):